4Helmy A.Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome[J].Aliment Pharmacol Ther,2006,23(1):11-25.
9Chen IL,Yang SN,Hsiao CC,Wu KS,Sheen JM.Treatment with high-dose methylprednisolone for hepatic veno-occlusive disease in a child with rhabdomyosarcoma[J].Pediatr Neonatol,2008,49(4):141-144.
10Benimetskaya L,Wu S,Voskresenskiy AM,Echart C,Zhou JF,Shin J, et al.Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease[J].Blood,2008,112(10):4343-4352.
7Baron F, Deprez M, Beguin Y. The veno-occlusive disease of the liver[ J]. Haematologica, 1997,82(6) :718.
8Carreras E, Bertz H, Arcesc W, et al. Incidence and outcome of hepatic veno-occlusiw disease after blood or marrow transplantation: a prospective cohort study of the European group for blood and marrow transplantation[J]. Blond,1998, 92(10) : 3599.
9McDonald OB, Hinds MS,Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients[J]. Ann Inter Med, 1993,118 (4) :225.
10DeLeve LD. Cellular target of cyclophosphamide toxicity in the munne liver:role of glutathione and site of metabolic activation[ J].Hepatol, 1996,24(4) :830.
